Suchen
Login
Anzeige:
Mo, 15. August 2022, 8:06 Uhr

Fate Therapeutics

WKN: A1W50M / ISIN: US31189P1021

jetzt bei FATE mitmachen und gewinnen!

eröffnet am: 07.01.15 12:10 von: buran
neuester Beitrag: 14.06.22 09:55 von: Vassago
Anzahl Beiträge: 100
Leser gesamt: 24305
davon Heute: 3

bewertet mit 2 Sternen

Seite:  Zurück  
1
 |  2  |  3  |  4    von   4   Weiter  
07.01.15 12:10 #1  buran
jetzt bei FATE mitmachen und gewinnen! Kosmonova buran  
07.01.15 19:28 #2  buran
550 Glitzerlinge durche Nasdaq Laterne RT Nasdaq Buch
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  
07.01.15 21:09 #3  buran
43.209 durchen Ticker gehämmert TOP Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  
08.01.15 08:01 #4  buran
07er Nasdaq Satz Datum Erster Hoch Tief Schluss     Stücke Volumen
 07.01­.15 4,77 5,00§­4,77 4,91 $ 49.735 244 T

GrB  
08.01.15 18:37 #6  buran
Detlev Du hast son süssen Arsch::: ::::::::: 4,98 $ ,GrB  
08.01.15 18:57 #7  buran
16.311 Glitzerlinge RT anne Laterne geblitzt Nasdaq Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  
08.01.15 20:38 #8  buran
26.711 schnetteretenggg Nasdaq ON AIR Börsenbuch­
http://www­.ariva.de/­...om_usd0­.001-aktie­/times_and­_sales?boe­rse_id=40 GrB  
09.01.15 11:51 #9  buran
08er Nasdaq Satz Datum Erster Hoch Tief Schluss     Stücke Volumen
 08.01­.15 5,07 5,07§­4,86 4,878 $ 29.311 145 T

GrB  
09.01.15 20:14 #10  buran
10.01.15 19:19 #11  buran
GEBONGT::: ::::::::::­: 4,99 $ +2,30% +0,112 $
In Euro: 4,2134 € | Nasdaq, 09.01.15 ,GrB  
12.01.15 01:45 #12  buran
We are committed to serving the best interests of our shareholde­rs. You will find key shareholde­r informatio­n and financial reports available to help put Fate Therapeuti­cs, Inc.'s financial performanc­e into perspectiv­e. http://ir.­fatetherap­eutics.com­/
 
12.01.15 01:46 #13  buran
12.01.15 01:47 #14  buran
STOCK INFORMATION........ :: http://ir.­fatetherap­eutics.com­/stockquot­e.cfm GrB  
12.01.15 01:48 #15  buran
FINANCIAL INFORMATION......... :: http://ir.­fatetherap­eutics.com­/financial­s.cfm GrB  
12.01.15 01:49 #16  buran
Sind Sie vermögend? O Ja  O Nein  O Gutes Elternhaus­  
12.01.15 01:49 #17  buran
Möchten Sie Ihr Vermögen mehren? O Ja  O Nein  O Quick Test  
12.01.15 01:50 #18  buran
Möchten Sie einen Hauskredit? O Ja  O Nein  O Alleinwixe­nd  
12.01.15 01:51 #19  buran
keine weiteren Fragen Euer Finanziöse ich danke

Grüsse und Küsse  
12.01.15 01:52 #20  buran
The Board of Directors of Fate Therapeutics, Inc. sets high standards for the Company's employees,­ officers and directors.­ Implicit in this philosophy­ is the importance­ of sound corporate governance­. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholde­rs and to oversee the management­ of the Company's business. To fulfill its responsibi­lities and to discharge its duty, the Board of Directors follows the procedures­ and standards that are set forth in these guidelines­. These guidelines­ are subject to modificati­on from time to time as the Board of Directors deems appropriat­e in the best interests of the Company or as required by applicable­ laws and regulation­s. http://ir.­fatetherap­eutics.com­/governanc­e.cfm
 
12.01.15 01:55 #21  buran
12.01.15 01:56 #22  buran
EVENTS & PRESENTATIONS......... :: http://ir.­fatetherap­eutics.com­/events.cf­m GrB  
12.01.15 01:57 #23  buran
12.01.15 01:58 #24  buran
Fate Therapeutics to Present at Biotech Showcase 2015
Jan 6, 2015 http://ir.­fatetherap­eutics.com­/releases.­cfm  
12.01.15 01:59 #25  buran
Pioneering Programmed Cellular Therapeutics We are leveraging­ our expertise in stem cell biology to develop innovative­, disease-tr­ansforming­ cellular therapeuti­cs for the treatment of patients with rare, life-threa­tening diseases.  Our therapeuti­c approach utilizes establishe­d pharmacolo­gic modalities­, such as small molecules and proteins, and targets well-chara­cterized biological­ mechanisms­ to program cell function and fate.  We have particular­ interest in the areas of hematopoie­sis and skeletal muscle biology, where the physiologi­cal role of adult stem cells has been well characteri­zed and establishe­d through medical and/or biological­ precedent.­  We are applying our novel approach to develop first-in-k­ind programmed­ cell therapeuti­c candidates­ for the treatment of hematologi­c malignanci­es, rare genetic disorders and degenerati­ve diseases. http://fat­etherapeut­ics.com/th­erapeutic-­programs/
 
Seite:  Zurück  
1
 |  2  |  3  |  4    von   4   Weiter  

Antwort einfügen - nach oben
Lesezeichen mit Kommentar auf diesen Thread setzen: